A Novel Antidiabetic Monomers Combination Alleviates Insulin Resistance Through Bacteria-Cometabolism-Inflammation Responses

A Novel Antidiabetic Monomers Combination Alleviates Insulin Resistance Through Bacteria-Cometabolism-Inflammation Responses

The present study sought to examine the therapeutic effect of a novel antidiabetic monomer combination (AMC) in treating type 2 diabetes mellitus (T2DM); while also elucidating the potential functional mechanism. Male C57BL/6J mice were fed a high-fat diet (HFD) for 12 weeks to establish T2DM. The A...

Full description

Bibliographic Details
Main Authors: Lin Han, Lin-Hua Zhao, Ming-Liang Zhang, Hua-Ting Li, Ze-Zheng Gao, Xiao-Jiao Zheng, Xin-Miao Wang, Hao-Ran Wu, Yu-Jiao Zheng, Xiao-Tian Jiang, Qi-You Ding, Hao-Yu Yang, Wei-Ping Jia, Xiao-Lin Tong
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Microbiology
Subjects:
antidiabetic monomer combination
insulin resistance
bacteria
cometabolism
inflammation
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2020.00173/full

Internet

https://www.frontiersin.org/article/10.3389/fmicb.2020.00173/full

Similar Items